Efficacy of Dasatinib in a CML Patient in Blast Crisis with F317L Mutation: A Case Report and Literature Review

by E.V. Morozova, Y.Y. Vlasova, M.V. Pryanishnikova, K.V. Lepik, B.V. Afanasyev
Published 2015-12-01

Efficacy of Dasatinib in a CML Patient in Blast Crisis with F317L Mutation: A Case Report and Literature Review

by E.V. Morozova, Y.Y. Vlasova, M.V. Pryanishnikova, K.V. Lepik, B.V. Afanasyev
Published 2015-01-01

GENE-CELL THERAPY OF HIV AND HEMATOLOGICAL MALIGNANCES BASED ON HEMATOPOIETIC STEM CELL TRANSPLANTATION AND SITE-SPECIFIC GENOME EDITING

by M. О. Popova, V. S. Sergeev, K V. Lepik, A. I. Shakirova, A. Ya. Potter, I. M. Barhatov, B. Fehse, B. V. Afanasyev
Published 2017-04-01

Efficacy and safety of nivolumab in the treatment of relapsed/refractory classical Hodgkin’s lymphoma: Pavlov First Saint Petersburg State Medical University experience

by K. V. Lepik, N. V. Mikhailova, E. V. Kondakova, L. A. Tsvetkova, Yu. R. Zalyalov, E. S. Borzenkova, I. S. Moiseev, V. V. Baykov, B. A. Afanasyev
Published 2019-01-01

Development of murine model of allogeneic bone marrow transplantation and graft-versus-host disease

by I. S. Moiseev, E. A. Burmina, A. V. Botina, M. O. Popova, A. R. Muslimov, O. G. Smykova, K. V. Lepik, K. V. Melsitova, A. I. Shakirova, I. M. Barkhatov, V. V. Baikov, O. V. Galibin
Published 2016-12-01